期刊文献+

RON、Hepsin和C-Met在浸润性乳腺癌中的表达及其意义 被引量:2

The Expression and Significance of RON,Hepsin and C-Met in Breast Cancer
下载PDF
导出
摘要 目的探讨浸润性乳腺癌组织中RON和Hepsin、C-Met的免疫表达及其意义。方法采用免疫组化PV-6000法检测了87例浸润性乳腺癌组织中RON和Hepsin、C-Met基因的表达情况。结果Hepsin、C-Met、RON在87例浸润性乳腺癌组织中的阳性表达率分别为70.1%、64.4%、65.5%,三者的阳性表达两两呈正相关(P<0.01),同时与浸润性乳腺癌的病理学分级、淋巴结转移亦呈正相关性(P<0.01)。结论Hepsin、C-Met、RON与浸润性乳腺癌的预后因素有相关性,联合检测可以更好地提示患者的预后。 Objective To study the relationship and the significance among the expressions of hepsin, C-Met and RON in breast cancer. Methods The expression of hepsin, C-Met and RON in the tissues from 87 patients with breast cancer was analyzed by immunohsitochemistry. Results The expression of RON, Heosin and C-Met was positively correlated. The expression of RON,hepsin and C-Met was related to the pathological grade and lymph node metastasis. Conclusion Hepsin, C-Met and RON might related to the prognosis of breast cancer.
作者 仇加高
出处 《实用癌症杂志》 2009年第6期584-586,共3页 The Practical Journal of Cancer
关键词 乳腺癌 RON基因 Hepsin基因 C—Met基因 免疫组织化学 Breast cancer RON gene Hepsin gene C-Met gene Imunohsitochemical
  • 相关文献

参考文献1

二级参考文献83

  • 1Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S.The protein kinase complement of the human genome. Science 2002; 298: 1912-34.
  • 2Bottaro DP, Rubin JS, Faletto DL, Chart AM, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251 : 802-4.
  • 3Williams TA, Longati P, Pugliese L, Gual P, Bardelli A, Michieli P. MET(PRC) mutations in the RON receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential. J Cell Physiol 1999; 181: 507-14.
  • 4Chen YQ, Zhou YQ, Fu LH, Wang D, Wang MH. Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Carcinogenesis 2002; 23:1811-9.
  • 5Zhou YQ, Chen YQ, Fisher JH, Wang MH. Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo. Oncogene 2002; 21: 6382-6.
  • 6Barkley JE, Green MR. Bronchioloalveolar carcinoma. J Clin Oncol 1996; 14: 2377-86.
  • 7Thiery JP, Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 1999; 18: 31-42.
  • 8Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001; 23: 912-23.
  • 9Wang D, Shen Q, Chen YQ, Wang MH. Collaborative activities of macrophage-stimulating protein and transforming growth factor-betal in induction of epithelial to mesenchymal transition:roles of the RON receptor tyrosine kinase. Oncogene 2004; 23:1668-80.
  • 10Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev 2000; 11: 15-22.

共引文献7

同被引文献31

  • 1张超,崔恒,钱和年.卵巢癌化疗药物的新进展[J].中国妇产科临床杂志,2001,2(4):245-248. 被引量:2
  • 2赵伟光,张建林,吴建国,朱应,李雁,朱忠超,刘志苏.HBx蛋白与Hepsin共表达可促进HBV复制[J].中国病毒学,2004,19(4):345-348. 被引量:1
  • 3梁文立,周利群,辛殿琪,那彦群.差异表达基因Hepsin在前列腺癌中的表达及其意义[J].中国康复理论与实践,2006,12(12):1060-1062. 被引量:1
  • 4曹泽毅主编.中华妇产科学[M].第2版,北京:人民卫生出版社,2008:398-419.
  • 5Lee CK, Simes P,J, Brown C, et al. A prognostic nomogram to predict overall survival in patients with platinum - sensitive recurrent ovarian cancer. Ann Oncol, 2012, 3: 57- 68.
  • 6Yin MZ, Li C, Li X, et al. Over- expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. J Surg Oncol, 2011, 104: 29-36.
  • 7Vin MZ, Xu Y, Lou G, et al. LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis. Int J Cancer, 2011, 129: 629- 635.
  • 8Xing P, Li JG, Jin F, et al. Clinical and biological signifi- cance of hepsin overexpression in breast cancer. J Investig Med, 2011, 59: 803-810.
  • 9Pace G, Pomante R, Vicentini C. Hepsin in the diagnosis of prostate cancer. Minerva Urol Nefrol, 2012, 64: 143- 148.
  • 10Miao J, Mu D, Ergel B, et al. Hepsin colocalizes with desmo- somes and induces progression of ovarian cancer in a mouse mod- el. Int J Cancer, 2008, 123: 2041- 2047.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部